CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 300 enrolled
Drug / intervention
WaveLight® EX500device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06668909
NCT06668909N/ACompleted
CompareCT.gov

Patient Reported Outcomes on Vision Quality and Dry Eye Following Treatment With Wavelight LASIK

OVO LASIK + Lens·observational·Posted Nov 1, 2024·Updated Mar 23, 2026

In Brief

An observational study evaluating WaveLight® EX500 for Myopia. Completed, enrolled 300 participants across 4 sites.

Detailed Summary

This study is a multi-site, single-arm, ambispective, observational study of subject satisfaction, after successful bilateral LASIK surgery. Subjects will be assessed 12+ months post-operatively. Clinical evaluations will include administration of the OSDI, modified PROWL, and dry eye questionnaires.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsMyopia
CountriesUnited States
CollaboratorsSengi

Timeline

N/ACompletedFinished
20252026
First PostedNov 1, 2024
Enrollment StartNov 1, 2024
Primary CompletionFeb 14, 2025
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 1.7 years ago

Interventions

WaveLight® EX500device

Phorcidies Planned Contoura LASIK